3.0850
+0.0300
+(0.98%)
At close: April 11 at 8:02:31 AM GMT+2
Loading Chart for SBX.MU
- Previous Close
3.0550 - Open
3.0850 - Bid 3.0750 x --
- Ask 3.3050 x --
- Day's Range
3.0850 - 3.0850 - 52 Week Range
3.0300 - 10.7500 - Volume
0 - Avg. Volume
40 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Apr 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: SBX.MU
View MorePerformance Overview: SBX.MU
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
SBX.MU
29.57%
DAX P (^GDAXI)
2.34%
1-Year Return
SBX.MU
69.75%
DAX P (^GDAXI)
13.48%
3-Year Return
SBX.MU
83.69%
DAX P (^GDAXI)
43.55%
5-Year Return
SBX.MU
89.20%
DAX P (^GDAXI)
92.85%
Compare To: SBX.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.8040
+4.55%
Mkt Cap EUR 151M
Industry Drug Manufacturers—Specialty & Generic
1.3000
+9.24%
Mkt Cap CAD 237.203M
Industry Drug Manufacturers—Specialty & Generic
0.4874
-3.56%
Mkt Cap 485.877M
Industry Drug Manufacturers—Specialty & Generic
Statistics: SBX.MU
View MoreValuation Measures
As of 4/10/2025
Market Cap
17.05M
Enterprise Value
17.93M
Trailing P/E
--
Forward P/E
51.02
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.76
Price/Book (mrq)
1.08
Enterprise Value/Revenue
4.64
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--